Correction to: Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group

Int J Hematol. 2020 Dec;112(6):906. doi: 10.1007/s12185-020-03019-0.

¹ Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
² Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4, Sakamoto, Nagasaki city, Nagasaki, Japan. itonaga-ngs@umin.ac.jp.
³ Department of Pathology, Sasebo City General Hospital, Sasebo, Japan.
⁴ Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.
⁵ Department of Hematology, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
⁶ Department of Hematology, Nagasaki Prefecture Gotochuoh Hospital, Goto, Japan.
⁷ Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
⁸ Department of Hematology, Sasebo City General Hospital, Sasebo, Japan.
⁹ Department of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.
¹⁰ Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4, Sakamoto, Nagasaki city, Nagasaki, Japan.

Abstract

In the original publication of the article, the authors would like to alter the color of characters in the Supplemental Table 1 and 2.